These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 21933172
1. Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer-designed synthetic peptides. Lebreton A, Moreau V, Lapalud P, Cayzac C, André S, Nguyen C, Schved JF, Lavigne G, Granier C. Br J Haematol; 2011 Nov; 155(4):487-97. PubMed ID: 21933172 [Abstract] [Full Text] [Related]
2. Computer-predicted peptides that mimic discontinuous epitopes on the A2 domain of factor VIII. Lebreton A, Simon N, Moreau V, Demolombe V, Cayzac C, Nguyen C, Schved JF, Granier C, Lavigne-Lissalde G. Haemophilia; 2015 May; 21(3):e193-e201. PubMed ID: 25422151 [Abstract] [Full Text] [Related]
3. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains. Gharagozlou S, Sharifian RA, Khoshnoodi J, Karimi K, Milani M, Okita DK, Shokri F, Conti-Fine BM. Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535 [Abstract] [Full Text] [Related]
4. Reactivity profile of anti-factor VIII antibodies with designed synthetic peptides mimicking epitopes of the C2 and a1 domains. Chaves DG, Velloso-Rodrigues C, Moreau V, Nguyen C, Villard S, Belisário AR, Granier C, Santoro MM. Br J Haematol; 2008 May; 141(5):708-15. PubMed ID: 18422780 [Abstract] [Full Text] [Related]
5. Human factor VIII inhibitor alloantibodies with a C2 epitope inhibit factor Xa-catalyzed factor VIII activation: a new anti-factor VIII inhibitory mechanism. Nogami K, Shima M, Nishiya K, Sakurai Y, Tanaka I, Giddings JC, Saenko EL, Yoshioka A. Thromb Haemost; 2002 Mar; 87(3):459-65. PubMed ID: 11916079 [Abstract] [Full Text] [Related]
6. Epitope mapping of polyclonal clotting factor VIII-inhibitory antibodies using phage display. Mühle C, Schulz-Drost S, Khrenov AV, Saenko EL, Klinge J, Schneider H. Thromb Haemost; 2004 Mar; 91(3):619-25. PubMed ID: 14983240 [Abstract] [Full Text] [Related]
8. Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes. Suzuki H, Shima M, Arai M, Kagawa K, Fukutake K, Kamisue S, Nakai H, Morichika S, Tanaka I, Inoue M, Gale K, Tuddenham EG, Yoshioka A. Thromb Haemost; 1997 May; 77(5):862-7. PubMed ID: 9184393 [Abstract] [Full Text] [Related]
10. Mapping of natural anti-factor VIII antibodies in plasma pools from healthy donors: use of rationally designed synthetic peptides. Di Giambattista M, Branckaert T, Laub R. Biologicals; 2001 May; 29(3-4):229-32. PubMed ID: 11851320 [Abstract] [Full Text] [Related]
11. Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia A patients with factor VIII inhibitor. Sugihara T, Takahashi I, Kojima T, Okamoto Y, Yamamoto K, Kamiya T, Matsushita T, Saito H. Nagoya J Med Sci; 2000 May; 63(1-2):25-39. PubMed ID: 10911718 [Abstract] [Full Text] [Related]
12. A putative inhibitory mechanism in the tenase complex responsible for loss of coagulation function in acquired haemophilia A patients with anti-C2 autoantibodies. Matsumoto T, Nogami K, Ogiwara K, Shima M. Thromb Haemost; 2012 Feb; 107(2):288-301. PubMed ID: 22234708 [Abstract] [Full Text] [Related]
13. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene. Pashov AD, Calvez T, Gilardin L, Maillère B, Repessé Y, Oldenburg J, Pavlova A, Kaveri SV, Lacroix-Desmazes S. Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514 [Abstract] [Full Text] [Related]
14. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity. Towfighi F, Gharagozlou S, Sharifian RA, Kazemnejad A, Esmailzadeh K, Managhchi MR, Shokri F. Acta Haematol; 2005 Mar; 114(2):84-90. PubMed ID: 16103630 [Abstract] [Full Text] [Related]
15. Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes. Gilles JG, Lavend'homme R, Peerlinck K, Jacquemin MG, Hoylaerts M, Jorieux S, Mazurier C, Vermylen J, Saint-Remy JM. Thromb Haemost; 1999 Jul; 82(1):40-5. PubMed ID: 10456452 [Abstract] [Full Text] [Related]
16. In silico prediction of FVIII epitopes recognised by natural autoantibodies in polyvalent immunoglobulin concentrates. Di Giambattista M, Branckaert T, Hougardy V, Kemball-Cook G, Laub R. Mol Immunol; 2007 Mar; 44(8):1903-13. PubMed ID: 17113150 [Abstract] [Full Text] [Related]
17. Simultaneous detection and epitope mapping of anti-factor VIII antibodies. Lavigne-Lissalde G, Tarrade C, Lapalud P, Chtourou S, Schved JF, Granier C, Villard-Saussine S. Thromb Haemost; 2008 Jun; 99(6):1090-6. PubMed ID: 18521513 [Abstract] [Full Text] [Related]
18. The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups. Prescott R, Nakai H, Saenko EL, Scharrer I, Nilsson IM, Humphries JE, Hurst D, Bray G, Scandella D. Blood; 1997 May 15; 89(10):3663-71. PubMed ID: 9160671 [Abstract] [Full Text] [Related]
19. Immunodominant T-cell epitopes in the factor VIII C2 domain are located within an inhibitory antibody binding site. Pratt KP, Qian J, Ellaban E, Okita DK, Diethelm-Okita BM, Conti-Fine B, Scott DW. Thromb Haemost; 2004 Sep 15; 92(3):522-8. PubMed ID: 15351848 [Abstract] [Full Text] [Related]
20. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays. Kopecky EM, Greinstetter S, Pabinger I, Buchacher A, Römisch J, Jungbauer A. J Immunol Methods; 2006 Jan 20; 308(1-2):90-100. PubMed ID: 16376372 [Abstract] [Full Text] [Related] Page: [Next] [New Search]